MyFinsight
Home
Blog
About
Cash and cash
equivalents
$243,733K
(65.15%↑ Y/Y)
Prepaid expenses and
other current assets
$3,586K
(58.60%↑ Y/Y)
Total current assets
$247,319K
(65.05%↑ Y/Y)
Operating right-of-use
asset
$3,858K
(-17.09%↓ Y/Y)
Property and equipment,
net
$2,051K
(-11.14%↓ Y/Y)
Restricted cash
$500K
(0.00%↑ Y/Y)
Other assets
$338K
(-40.70%↓ Y/Y)
Total assets
$254,066K
(60.93%↑ Y/Y)
Total liabilities and
stockholders equity
$254,066K
(60.93%↑ Y/Y)
Total stockholders
equity
$219,249K
(77.66%↑ Y/Y)
Total liabilities
$34,817K
(1.02%↑ Y/Y)
Accumulated deficit
-$255,509K
(-49.18%↓ Y/Y)
Additionalpaid-incapital
$474,738K
(61.12%↑ Y/Y)
Total current
liabilities
$16,652K
(104.85%↑ Y/Y)
Term
loan,non-current
$12,419K
(-38.28%↓ Y/Y)
Lease liability,
long-term
$3,281K
(-22.14%↓ Y/Y)
Convertible grant agreement
$2,465K
(23.25%↑ Y/Y)
Accumulated other
comprehensive loss
$17K
(-45.16%↓ Y/Y)
Common stock (par value
0.0001), 500,000 shares...
$3K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$8,863K
(37.24%↑ Y/Y)
Accounts payable
$4,021K
(140.63%↑ Y/Y)
Term loan, current
$3,768K
Back
Back
Balance Sheet
Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience, Inc. (ANRO)
source: myfinsight.com